HLA-DPB1*05:01 genotype is associated with poor response to sublingual immunotherapy for Japanese cedar pollinosis

Allergy. 2022 May;77(5):1633-1635. doi: 10.1111/all.15254. Epub 2022 Feb 26.

Authors

Masanori Kidoguchi^{1

2}, Wataru Morii¹, Emiko Noguchi¹, Atsushi Yuta³, Yukiko Ogawa³, Takako Nakamura¹, Hirotaka Kikuoka⁴, Hideaki Kouzaki⁴, Hiroyuki Arai⁴, Rieko Ii¹, Naoto Adachi^{1

2}, Keisuke Koyama², Takahiro Ninomiya², Yoshimasa Imoto², Masafumi Sakashita², Shigeharu Fujieda²

Affiliations

¹ Department of Medical Genetics, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
² Division of Otorhinolaryngology and Head & Neck Surgery, Department of Sensory and Locomotor Medicine, Faculty of Medical Science, University of Fukui, Fukui, Japan.
³ Yuta Clinic, Mie, Japan.
⁴ Department of Otorhinolaryngology and Head & Neck Surgery, Shiga University of Medical Science, Shiga, Japan.

PMID: 35150450
DOI: 10.1111/all.15254

No abstract available

Keywords: HLA-DPB1; Japanese cedar pollinosis; allergic rhinitis; pharmacogenetics; sublingual immunotherapy.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Allergens
Cryptomeria*
Genotype
HLA-DP beta-Chains
Humans
Japan
Rhinitis, Allergic, Seasonal* / complications
Rhinitis, Allergic, Seasonal* / therapy
Sublingual Immunotherapy*

Substances

Allergens
HLA-DP beta-Chains
HLA-DPB1 antigen